| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Paras Agarwal, Adanegbe Omoruyi, Kiara Gascon Perai, Kerenza MacDaid, Andrea Burto. Neuroleptic Malignant Syndrome (NMS) on Clozapine with a Potential Atypical Interaction with Paliperidone. Case reports in psychiatry. vol 2021. 2021-05-20. PMID:34007505. |
neuroleptic malignant syndrome (nms) on clozapine with a potential atypical interaction with paliperidone. |
2021-05-20 |
2023-08-13 |
Not clear |
| Paras Agarwal, Adanegbe Omoruyi, Kiara Gascon Perai, Kerenza MacDaid, Andrea Burto. Neuroleptic Malignant Syndrome (NMS) on Clozapine with a Potential Atypical Interaction with Paliperidone. Case reports in psychiatry. vol 2021. 2021-05-20. PMID:34007505. |
neuroleptic malignant syndrome (nms) associated with the use of first-generation antipsychotics is a widely known phenomenon. |
2021-05-20 |
2023-08-13 |
Not clear |
| Qiang Wang, Jiabo Shi, Peng Zhao, Qiuyun Cao, Zhijian Ya. Neuroleptic malignant syndrome with abnormally elevated cardiac troponin I: a case report. The Journal of international medical research. vol 48. issue 11. 2021-05-14. PMID:33203271. |
neuroleptic malignant syndrome (nms) is a life-threatening neurological emergency that is primarily characterized by altered consciousness, hyperpyrexia, muscular rigidity, and autonomic instability. |
2021-05-14 |
2023-08-13 |
Not clear |
| Brooke J Olson, Mohan S Dhariwa. Neuroleptic Malignant Syndrome: A Case of Unknown Causation and Unique Clinical Course. Cureus. vol 13. issue 3. 2021-05-02. PMID:33927924. |
neuroleptic malignant syndrome (nms) is a rare, potentially lethal syndrome known to be related to the initiation of dopamine antagonist medications or rapid withdrawal of dopaminergic medications. it is a diagnosis of exclusion with a known sequela of symptoms, but not all patients experience these characteristic symptoms making it difficult at times to diagnose and treat. |
2021-05-02 |
2023-08-13 |
Not clear |
| Kulwant Buttar, Eileen Trigoboff, Jeffery J Grac. Neuroleptic Malignant Syndrome: Can Be an Unrecognized Chronic Fatal Disease. Innovations in clinical neuroscience. vol 17. issue 10-12. 2021-04-28. PMID:33898100. |
this case report concentrates on the fatal consequences of the chronic aspects of neuroleptic malignant syndrome (nms). |
2021-04-28 |
2023-08-13 |
Not clear |
| Tamadhir Al-Mahrouqi, Ameera Al-Kindi, Ahmed Al-Harras. Crippling Side Effects Induced by Paliperidone Palmitate Treatment: A Case Report. Cureus. vol 13. issue 2. 2021-04-03. PMID:33796427. |
it appears that even though the long-acting paliperidone palmitate prescription had improved her psychotic symptoms, it also induced several potentially life-threatening conditions. this case report highlights the diagnostic challenge represented by the overlapping features of the neuroleptic malignant syndrome (nms) and extrapyramidal side effects (eps). |
2021-04-03 |
2023-08-13 |
Not clear |
| Eduardo D Espiridion, Valli Mani, Adeolu O Oladunjoy. Neuroleptic Malignant Syndrome After Re-introduction of Atypical Antipsychotics in a COVID-19 Patient. Cureus. vol 13. issue 2. 2021-03-26. PMID:33763319. |
we present a case of neuroleptic malignant syndrome (nms) in a 46-year-old white female from a state psychiatric hospital who also tested positive for coronavirus-2019 (covid-19) (severe acute respiratory syndrome coronavirus, sars-cov-2) infection after re-introduction of her home antipsychotics medication. |
2021-03-26 |
2023-08-13 |
Not clear |
| Rajani Rajan, Mary Sag. Successful Emergency Treatment of Refractory Neuroleptic Malignant Syndrome With Electroconvulsive Therapy and a Novel Use of Dexmedetomidine: A Case Report From California in the Era of COVID-19. The journal of ECT. vol 37. issue 1. 2021-02-24. PMID:33600120. |
we describe the case of a patient, hospitalized in a california community medical icu for over a month, with severe neuroleptic malignant syndrome (nms), unresponsive to medical management, but responsive to electroconvulsive therapy (ect). |
2021-02-24 |
2023-08-13 |
Not clear |
| Sheila D Hernandez, Dario A Marotta, Ravitej Gotet. Atypical Neuroleptic Malignant Syndrome in the Setting of Quetiapine Overdose: A Case Report and Review of the Literature. Cureus. vol 13. issue 1. 2021-02-16. PMID:33585092. |
neuroleptic malignant syndrome (nms) is a rare and life-threatening emergency. |
2021-02-16 |
2023-08-13 |
Not clear |
| Ho-Man Yeung, Sarah Schmitz, Nino Kvantaliani, Christina Marti. Development of Neuroleptic Malignant Syndrome in a Patient with Lewy Body Dementia after Intramuscular Administration of Paliperidone. Case reports in neurological medicine. vol 2021. 2021-02-02. PMID:33520321. |
neuroleptic malignant syndrome (nms) is a potentially fatal diagnosis composed of hyperpyrexia, muscle rigidity, altered mental status, and autonomic instability. |
2021-02-02 |
2023-08-13 |
Not clear |
| Hein Bokern, Niels Jonker, Dan Cohe. Creatine kinase elevation and discontinuation of clozapine: fear-driven clinical practice in a forensic case with treatment-resistant schizophrenia and persistent violent behaviour. BJPsych open. vol 7. issue 1. 2021-01-16. PMID:33272348. |
we present a case in which treatment with clozapine proved effective in spite of earlier repeated discontinuation of clozapine out of fear of neuroleptic malignant syndrome (nms). |
2021-01-16 |
2023-08-13 |
Not clear |
| Micheal Kiyingi, Felix Bongomin, Mark Kizito, Mark Kaddumukas. Neuroleptic Malignant Syndrome: Early Diagnosis Saves Lives in Low-Resource Settings. International medical case reports journal. vol 13. 2020-12-29. PMID:32904592. |
neuroleptic malignant syndrome (nms) is an uncommon but serious adverse event to antipsychotic medications. |
2020-12-29 |
2023-08-13 |
Not clear |
| Müge Ayanoğlu, Elif Korgali, Taner Sezer, Halil Ibrahim Aydin, Fatma Müjgan Sönme. Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation. Brain & development. vol 42. issue 5. 2020-12-21. PMID:32173091. |
we describe the first child with guanidinoacetate methyltransferase (gamt) deficiency who developed neuroleptic malignant syndrome (nms) after the treatment of risperidone without elevated creatine kinase (ck) levels. |
2020-12-21 |
2023-08-13 |
Not clear |
| Anna Maria Szota, Izabela Radajewska, Przemysław Grudzka, Aleksander Araszkiewic. Lamotrigine, quetiapine and aripiprazole-induced neuroleptic malignant syndrome in a patient with renal failure caused by lithium: a case report. BMC psychiatry. vol 20. issue 1. 2020-12-21. PMID:32306929. |
neuroleptic malignant syndrome (nms) may be induced by atypical antipsychotic drugs (aapds) such as aripiprazole, olanzapine, risperidone and quetiapine, either as a single treatment or in combination with other drugs. |
2020-12-21 |
2023-08-13 |
Not clear |
| Izumi Sato, Hideki Onishi, Chiaki Kawanishi, Shuhei Yamada, Mayumi Ishida, Koji Kawakam. Neuroleptic malignant syndrome in patients with cancer: a systematic review. BMJ supportive & palliative care. vol 10. issue 3. 2020-12-09. PMID:32414787. |
antipsychotics potentially cause a low incidence of the side effect called neuroleptic malignant syndrome (nms), which has a high mortality rate. |
2020-12-09 |
2023-08-13 |
Not clear |
| Mitsuhito Soh, Toru Hifumi, Shutaro Isokawa, Masato Shimizu, Norio Otani, Shinichi Ishimats. Neuroleptic malignant syndrome in patients with COVID-19. The American journal of emergency medicine. vol 38. issue 10. 2020-12-09. PMID:32473756. |
we report the first two cases of coronavirus disease 2019 (covid-19) who were receiving intensive care including favipiravir, and were clinically diagnosed with neuroleptic malignant syndrome (nms) to focus attention on nms in covid-19 management. |
2020-12-09 |
2023-08-13 |
Not clear |
| Carlos Schönfeldt-Lecuona, Lilli Kuhlwilm, Maximilian Cronemeyer, Peter Neu, Bernhard J Connemann, Maximilian Gahr, Alexander Sartorius, Viktoria Mühlbaue. Treatment of the Neuroleptic Malignant Syndrome in International Therapy Guidelines: A Comparative Analysis. Pharmacopsychiatry. vol 53. issue 2. 2020-12-07. PMID:31820427. |
the neuroleptic malignant syndrome (nms) is a potentially life-threatening condition associated to the use of antipsychotics. |
2020-12-07 |
2023-08-13 |
Not clear |
| Michael Schneider, Johannes Regente, Timo Greiner, Stephanie Lensky, Stefan Bleich, Sermin Toto, Renate Grohmann, Susanne Stübner, Martin Heinz. Neuroleptic malignant syndrome: evaluation of drug safety data from the AMSP program during 1993-2015. European archives of psychiatry and clinical neuroscience. vol 270. issue 1. 2020-11-06. PMID:30506147. |
neuroleptic malignant syndrome (nms) is a rare, but severe adverse drug reaction of drugs with anti-dopaminergic properties. |
2020-11-06 |
2023-08-13 |
Not clear |
| Juan Fernando Ortiz, Martín Wirth, Noha Eskander, Jazmin Carolina Cozar, Olumuyiwa Fatade, Bindu Ratho. The Genetic Foundations of Serotonin Syndrome, Neuroleptic Malignant Syndrome, and Malignant Hyperthermia: Is There a Genetic Association Between These Disorders? Cureus. vol 12. issue 9. 2020-10-31. PMID:33123448. |
neuroleptic malignant syndrome (nms), serotonin syndrome (ss), and malignant hyperthermia (mh) share similar clinical characteristics. |
2020-10-31 |
2023-08-13 |
human |
| Kishan Raj, T R Jajor, Ashish Khandelwal, Gaurav Goya. Neuroleptic Malignant Syndrome with Minimal Dose of Amisulpride. Journal of acute medicine. vol 7. issue 3. 2020-10-02. PMID:32995183. |
neuroleptic malignant syndrome (nms) with amisulpride is rare, and have been reported earlier. |
2020-10-02 |
2023-08-13 |
Not clear |